tiprankstipranks
Trending News
More News >
Dabur India Limited (IN:DABUR)
:DABUR
India Market
Advertisement

Dabur India Limited (DABUR) AI Stock Analysis

Compare
6 Followers

Top Page

IN:DABUR

Dabur India Limited

(DABUR)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 4o)
Rating:67Neutral
Price Target:
₹552.00
▲(8.53% Upside)
Dabur India Limited's strong financial performance is the most significant factor, supported by a robust balance sheet and consistent revenue growth. However, technical indicators suggest potential short-term weakness, and the high P/E ratio indicates overvaluation concerns. The absence of earnings call data and notable corporate events limits further insights.

Dabur India Limited (DABUR) vs. iShares MSCI India ETF (INDA)

Dabur India Limited Business Overview & Revenue Model

Company DescriptionDabur India Limited operates as a fast-moving consumer goods company worldwide. It operates through Consumer Care Business, Foods Business, Retail Business, and Other segments. The company manufactures and sells health supplements under the Dabur Chyawanprash, Dabur Vita, Dabur Honey, Dabur Immunity Kit, Dabur Vedic Suraksha Tea, and Dabur Glucose brands; digestive products under the Dabur Hajmola, Pudin Hara, Hingoli, Dabur Nature Care, and Sat Isabgol brands; and shampoos under the Dabur Almond and Vatika brands. It also offers hair oils under the Dabur Amla, Vatika, Dabur Almond, and Anmol brands; skin care products under the Dabur Gulabari, Oxylife, and Dabur Fem brands; and oral care products under the Dabur Red Paste, Dabur Meswak, Dabur Babool, Dabur Lal Dant Manjan, Dabur Red Pulling Oil, and Dabur Dant Rakshak Ayurvedic Paste brands. In addition, the company provides fruit juices under the Real and Real Activ brands; various cooking pastes under the Hommade brand; and milk-based beverages under the Real Milk Power brand. Further, it offers energizers and rejuvenators under the Shilajit, Shilajit Gold, Shilajit Double Gold, and Dabur Musli Gold names; cough and cold products under the Dabur Honitus and Dabur Tulsi Drops brands name; health juices; women's health products, such as Dabur Dashmularishta and Dabur Ashokarishta; ayurvedic baby massage oil for babies under the Dabur Lal Tail name; and ayurvedic ethical products. Additionally, the company provides mosquito repellents under the Odomos brand name; air fresheners under the Odonil name; toilet cleaners under the Sanifresh Shine brand name; dish wash products under the Odopic name; and natural gum products under brand name DABISCO. It also operates specialized beauty retail stores that offer a range of cosmetics, fragrances, skin care, and personal care products, as well as beauty and fashion accessories under the NewU brand name. Dabur India Limited was founded in 1884 and is based in Ghaziabad, India.
How the Company Makes MoneyDabur generates revenue primarily through the sale of its diverse range of consumer goods. Key revenue streams include health care products (like dietary supplements), personal care items (such as shampoos and skincare products), and food products (including honey and juices). The company utilizes a multi-channel distribution strategy, selling products through modern retail outlets, traditional trade, e-commerce platforms, and direct-to-consumer channels. Significant partnerships with retailers and distributors enhance its market reach. Furthermore, Dabur has been expanding its international presence, tapping into markets in the Middle East, Africa, and Southeast Asia, which contributes to its earnings. The focus on innovation and product development, along with strong brand equity, further strengthens its revenue model.

Dabur India Limited Financial Statement Overview

Summary
Dabur India Limited demonstrates a strong financial position with growing revenues and solid profitability margins. The balance sheet is robust, with a healthy equity ratio and manageable debt levels. While cash flow metrics are stable, the decline in EBIT and free cash flow requires attention to sustain long-term growth.
Income Statement
78
Positive
Dabur India Limited has shown consistent revenue growth over the years, with a recent increase in total revenue from the previous year. The gross profit margin is robust, indicating effective cost management. However, there is a noticeable decline in EBIT, which suggests potential challenges in operational efficiency. Net profit margin remains healthy, but the decrease in EBIT margin is a concern.
Balance Sheet
82
Very Positive
The company's balance sheet is strong with a solid equity base, reflected in a favorable debt-to-equity ratio. Stockholders' equity has been growing consistently, enhancing financial stability. The equity ratio also indicates a sound financial structure with a good proportion of assets funded by equity.
Cash Flow
74
Positive
Operating cash flow remains steady, supporting the company's operations and investments. However, the free cash flow shows a slight decline, and the free cash flow to net income ratio is moderate, indicating that not all earnings are translating into cash flow. The company maintains a healthy operating cash flow to net income ratio, ensuring liquidity.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue126.19B125.63B122.62B114.27B108.08B94.93B
Gross Profit55.79B60.28B58.84B52.61B51.31B46.86B
EBITDA27.47B28.67B28.82B26.08B25.61B23.27B
Net Income17.81B17.68B18.43B17.07B17.39B16.93B
Balance Sheet
Total Assets0.00162.32B151.23B136.54B122.85B108.47B
Cash, Cash Equivalents and Short-Term Investments26.56B26.56B23.23B10.91B14.02B20.07B
Total Debt0.009.50B13.65B11.74B10.30B5.09B
Total Liabilities-112.10B50.22B48.20B42.13B38.63B31.47B
Stockholders Equity112.10B108.01B98.66B89.73B83.81B76.64B
Cash Flow
Free Cash Flow0.0014.17B14.50B9.79B14.28B18.03B
Operating Cash Flow0.0019.87B20.13B14.88B18.02B21.15B
Investing Cash Flow0.00-4.49B-9.72B-5.87B-12.75B-14.06B
Financing Cash Flow0.00-14.05B-11.61B-10.35B-4.90B-6.13B

Dabur India Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price508.60
Price Trends
50DMA
516.24
Negative
100DMA
505.74
Positive
200DMA
500.07
Positive
Market Momentum
MACD
-7.16
Negative
RSI
53.00
Neutral
STOCH
81.04
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DABUR, the sentiment is Positive. The current price of 508.6 is above the 20-day moving average (MA) of 499.56, below the 50-day MA of 516.24, and above the 200-day MA of 500.07, indicating a neutral trend. The MACD of -7.16 indicates Negative momentum. The RSI at 53.00 is Neutral, neither overbought nor oversold. The STOCH value of 81.04 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:DABUR.

Dabur India Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
₹953.92B57.021.43%16.58%9.72%
69
Neutral
₹6.12T56.692.03%2.93%4.47%
67
Neutral
₹902.10B50.611.57%-0.03%-5.22%
66
Neutral
₹1.16T62.481.77%5.12%
66
Neutral
₹624.41B44.812.22%2.12%-1.45%
66
Neutral
₹242.09B29.421.45%4.06%10.78%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:DABUR
Dabur India Limited
508.60
-50.66
-9.06%
IN:COLPAL
Colgate-Palmolive (India) Limited
2,295.75
-981.29
-29.94%
IN:EMAMILTD
Emami Limited
551.35
-131.60
-19.27%
IN:GODREJCP
Godrej Consumer Products Limited
1,132.40
-161.22
-12.46%
IN:HINDUNILVR
Hindustan Unilever Limited
2,604.75
-30.14
-1.14%
IN:MARICO
Marico Limited
734.95
82.61
12.66%

Dabur India Limited Corporate Events

Dabur India Promoters Affirm Unencumbered Shareholding
Apr 21, 2025

Dabur India Limited has disclosed that its promoters, along with Persons Acting in Concert (PAC), held over 1.17 billion equity shares as of March 31, 2025, without any encumbrance during the financial year. This announcement reinforces the promoters’ commitment to maintaining their stake in the company, potentially boosting investor confidence and stabilizing the company’s market position.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 18, 2025